Bacitracin 0.04 units, HardyDisks™, for the differentiation of Group A Strep (Streptococcus pyogenes)

Used in the presumptive identification of group A, beta-hemolytic streptococci. The test differentiates group A streptococci from other Lancefield groups of hemolytic streptococci by inhibiting the growth of group A streptococci around a disk containing approximately 0.04 units bacitracin.

Each cartridge contains 50 disks that are spring loaded for smooth and reliable dispensing from the single metal disk dispenser by BD BioSciences, Cat. no. 260457.

See below to view the Instructions For Use (IFU), MSDS, and color brochures that feature the many other rapid test methods offered by Hardy.

The Hardy Diagnostics manufacturing facility and quality management system comply with the FDA's Good Manufacturing Practices (GMP) and have achieved ISO 13485 certification as a medical device manufacturer.

Please contact us at for specific academic pricing.